SIC 8071 – Medical Laboratories
Valuation | |
---|---|
Market Cap ($M) | 11,417.36 |
Enterprise Value ($M) | 13,397.05 |
Book Value ($M) | 3,210.51 |
Book Value / Share | 17.35 |
Price / Book | 3.56 |
NCAV ($M) | -2,004.94 |
NCAV / Share | -10.83 |
Price / NCAV | -5.69 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.04 |
Return on Assets (ROA) | -0.03 |
Return on Equity (ROE) | -0.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.93 |
Current Ratio | 2.12 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,533.12 |
Assets | 6,748.57 |
Liabilities | 3,538.06 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Capital World Investors | 8.60 | 238.28 | |
13G/A | Wellington Management Group Llp | 7.93 | 39.06 | |
13G | Fmr Llc | 11.90 | 740.43 | |
13G/A | Jpmorgan Chase & Co | 4.00 | -56.63 | |
13G/A | Vanguard Group Inc | 9.71 | 1.78 | |
13G/A | BlackRock, Inc. | 6.10 | -2.21 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
323,731 | 1,423,797 | 22.74 | |
380,101 | 1,528,316 | 24.87 | |
256,523 | 963,187 | 26.63 | |
(click for more detail) |
Similar Companies | |
---|---|
BGLC – BioNexus Gene Lab Corp. | CELC – Celcuity Inc. |
MDXH – MDxHealth SA | PMD – Psychemedics Corporation |
VRDN – Viridian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io